Chemomab Therapeutics Ltd DRC (CMMB) — Cash Flow Quality Index

Latest as of December 2019: -0.69x

Chemomab Therapeutics Ltd DRC (CMMB) has a Cash Flow Quality Index of -0.69x as of December 2019. Operating cash flow of $-6.26 Million is below net income of $9.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chemomab Therapeutics Ltd DRC long-term investment allocation to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.69x

Operating CF / Net Income

Operating Cash Flow

$-6.26 Million

USD

Net Income

$9.08 Million

USD

Data as of

Dec 2019

Most recent filing

Annual Cash Flow Quality Index for Chemomab Therapeutics Ltd DRC (None–None)

Year-by-year earnings quality comparison for Chemomab Therapeutics Ltd DRC. For live market cap and the full company financial profile, see CMMB market cap overview.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.